Literature DB >> 836339

Glucocorticosteroid inhibition of nonphagocytic discharge of lysosomal enzymes from human neutrophils.

L J Ignarro.   

Abstract

Glucocorticosteroids and mineralocorticosteroids were tested for their capacity to inhibit the nonphagocytic discharge of two lysosomal enzymes--a cartilage matrix-degrading neutral protease and beta-glucuronidase--from highly purified human neutrophils. Lysosomal enzyme discharge from neutrophils adherent to nonphagocytizable, immobilized, heat-aggregated IgG was inhibited by the four glucocorticosteroids--methylprednisolone sodium succinate, triamcinolone acetonide hemisuccinate, para methasone acetate, and hydrocortisone sodium succinate. These glucocorticoids also inhibited zymosan-induced release of beta-glucuronidase from neutrophils that had been pretreated with cytochalasin B in order to completely prevent the onset of phagocytosis. Inhibition by the glucocorticoids of lysosomal enzyme discharge provoked by a soluble divalent cation ionophore was also observed. Neither desoxycorticosterone acetate nor aldosterone hemisuccinate, two mineralocorticosteroids, inhibited lysosomal enzyme release. Similarly, the salt moieties of some of the steroids tested, such as sodium succinate and sodium acetate, failed to elicit an effect on enzyme release. Therefore interference with lysosomal enzyme discharge was restricted to the glucocorticosteroid ring structure. Because interference either with the adherence of neutrophils to immune reactants or with the activities of the discharged lysosomal enzymes by the glucocorticoids could be interpreted as inhibition of lysosomal enzyme release, steroidal effects on these parameters were examined. None of the glucocorticoids tested elicited any significant effects on neutrophil adherence or lysosomal enzyme activity. Thus it appears that glucocorticosteroids are capable of inhibiting directly the nonphagocytic discharge of lysosomal enzymes from human neutrophils.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836339     DOI: 10.1002/art.1780200114

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Release of cartilage proteoglycan degrading enzyme activity by thioglycollate stimulated mouse peritoneal macrophages in culture.

Authors:  N Ackerman; S Jubb; B Trimble; B Yoxall
Journal:  Agents Actions       Date:  1979-12

2.  Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.

Authors:  S H Boghossian; D A Isenberg; G Wright; M L Snaith; A W Segal
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

3.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

4.  Inhibition of neutrophil superoxide production by fanetizole.

Authors:  B Styrt; R E Rocklin; M S Klempner
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

5.  Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Susan L Hogan; Patrick H Nachman; Caroline J Poulton; Yichun Hu; Lauren N Blazek; Meghan E Free; J Charles Jennette; Ronald J Falk
Journal:  Kidney Int Rep       Date:  2019-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.